Difficulty: Medium
Average Score: 93%
Practice
Indicate the vasoconstrictor of endogenous origin:
Correct answer
D
Rationale
In this question from the ATI Pharmacology Across the Lifespan exam, the correct answer is D) Angiotensinamide as the vasoconstrictor of endogenous origin.
Angiotensinamide is the correct answer because it is a peptide hormone that is naturally produced in the body and plays a crucial role in regulating blood pressure by causing vasoconstriction. This hormone is derived from angiotensinogen through the action of the enzyme renin.
Now, let's analyze why the other options are incorrect:
A) Ephedrine is a sympathomimetic amine that acts by stimulating adrenergic receptors, leading to vasoconstriction, but it is not of endogenous origin.
B) Phenylephrine is a synthetic sympathomimetic amine that acts as an alpha-1 adrenergic receptor agonist, causing vasoconstriction. It is not of endogenous origin.
C) Xylometazoline is a topical decongestant that acts by constricting blood vessels in the nasal passages but is not of endogenous origin.
Educational context: Understanding the sources and mechanisms of vasoconstrictors is essential in pharmacology. Knowing which substances are naturally produced in the body (endogenous) versus those that are synthetically produced (exogenous) helps healthcare professionals make informed decisions when treating conditions related to blood pressure regulation. This knowledge is vital for safe and effective medication administration and patient care.
Angiotensinamide is the correct answer because it is a peptide hormone that is naturally produced in the body and plays a crucial role in regulating blood pressure by causing vasoconstriction. This hormone is derived from angiotensinogen through the action of the enzyme renin.
Now, let's analyze why the other options are incorrect:
A) Ephedrine is a sympathomimetic amine that acts by stimulating adrenergic receptors, leading to vasoconstriction, but it is not of endogenous origin.
B) Phenylephrine is a synthetic sympathomimetic amine that acts as an alpha-1 adrenergic receptor agonist, causing vasoconstriction. It is not of endogenous origin.
C) Xylometazoline is a topical decongestant that acts by constricting blood vessels in the nasal passages but is not of endogenous origin.
Educational context: Understanding the sources and mechanisms of vasoconstrictors is essential in pharmacology. Knowing which substances are naturally produced in the body (endogenous) versus those that are synthetically produced (exogenous) helps healthcare professionals make informed decisions when treating conditions related to blood pressure regulation. This knowledge is vital for safe and effective medication administration and patient care.